Published in Front Immunol on April 24, 2017
Functions of natural killer cells. Nat Immunol (2008) 9.88
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol Ther (2007) 2.99
Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA (2011) 2.90
Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol (2009) 2.00
T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood (2000) 1.94
Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya. J Infect Dis (2007) 1.94
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis (2015) 1.70
Human NK cells display major phenotypic and functional changes over the life span. Aging Cell (2010) 1.65
High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics (2010) 1.47
Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol (2011) 1.33
The NICHD International Site Development Initiative perinatal cohorts (2002-09). Int J Epidemiol (2011) 1.25
Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol (1997) 1.23
Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis (2000) 1.21
Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Braz J Med Biol Res (2008) 1.17
Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants. AIDS (2011) 1.10
In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS (2014) 1.07
Immune responses in neonates. Expert Rev Clin Immunol (2014) 1.06
Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Pediatr (2010) 1.02
Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr (2014) 1.02
Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIV-uninfected infants. Immunology (2009) 0.99
Quality assurance program for peripheral blood mononuclear cell cryopreservation. Clin Vaccine Immunol (2007) 0.98
Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country. PLoS One (2015) 0.97
Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis (2010) 0.97
The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. Hum Immunol (2011) 0.93
Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagn Lab Immunol (1998) 0.91
HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis (2016) 0.88
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol (2012) 0.86
Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children. Front Immunol (2016) 0.86
Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers. AIDS (2007) 0.85
Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants. Pediatrics (2016) 0.84
Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus. PLoS One (2014) 0.84
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS (2013) 0.83
Impaired haemophilus influenzae type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but -uninfected infants. Clin Vaccine Immunol (2014) 0.83
Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants. PLoS One (2015) 0.82
Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants. Front Immunol (2016) 0.80
NKG2C gene deletion in the Mexican population and lack of association to respiratory viral infections. Int J Immunogenet (2013) 0.78
Formula feeding skews immune cell composition toward adaptive immunity compared to breastfeeding. J Immunol (2009) 0.78
HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era. Front Immunol (2016) 0.78
Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression. Viral Immunol (2015) 0.76
Recognition and Regulation of T Cells by NK Cells. Front Immunol (2016) 0.75
Diversity in KIR gene repertoire in HIV-1 exposed infected and uninfected infants: A study from India. J Med Virol (2015) 0.75
Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection. Int J Gynaecol Obstet (2015) 0.77
Long-term postpartum adherence to antiretroviral drugs among women in Latin America. Int J STD AIDS (2015) 0.76
Late Onset Hypomorphic RAG2 Deficiency Presentation with Fatal Vaccine-Strain VZV Infection. J Clin Immunol (2015) 0.75